Overview Efficacy and Safety of ETX 018810 in Subjects With Lumbosacral Radicular Pain Status: Recruiting Trial end date: 2021-10-30 Target enrollment: Participant gender: Summary Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain Phase: Phase 2 Details Lead Sponsor: Eliem Therapeutics (UK) Ltd.